226 related articles for article (PubMed ID: 30390772)
1. Management of Vestibular Schwannoma (Including NF2): Facial Nerve Considerations.
Kaul V; Cosetti MK
Otolaryngol Clin North Am; 2018 Dec; 51(6):1193-1212. PubMed ID: 30390772
[TBL] [Abstract][Full Text] [Related]
2. Controversies in building a management algorithm for vestibular schwannomas.
Doherty JK; Friedman RA
Curr Opin Otolaryngol Head Neck Surg; 2006 Oct; 14(5):305-13. PubMed ID: 16974142
[TBL] [Abstract][Full Text] [Related]
3. Sporadic vestibular schwannoma in a pediatric population: a case series.
Kosaraju N; Moore LS; Mulders JY; Blevins NH
Childs Nerv Syst; 2024 Mar; 40(3):635-645. PubMed ID: 37889276
[TBL] [Abstract][Full Text] [Related]
4. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
[TBL] [Abstract][Full Text] [Related]
5. Facial nerve function and hearing after microsurgical removal of sporadic vestibular schwannomas in a population-based cohort.
Taha I; Hyvärinen A; Ranta A; Kämäräinen OP; Huttunen J; Mervaala E; Löppönen H; Rauramaa T; Ronkainen A; Jääskeläinen JE; Immonen A; Danner N
Acta Neurochir (Wien); 2020 Jan; 162(1):43-54. PubMed ID: 31494730
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and Management of Vestibular Schwannomas - An Interdisciplinary Challenge].
Rosahl S; Bohr C; Lell M; Hamm K; Iro H
Laryngorhinootologie; 2017 Apr; 96(S 01):S152-S182. PubMed ID: 29036751
[TBL] [Abstract][Full Text] [Related]
7. A matched cohort comparison of clinical outcomes following microsurgical resection or stereotactic radiosurgery for patients with small- and medium-sized vestibular schwannomas.
Golfinos JG; Hill TC; Rokosh R; Choudhry O; Shinseki M; Mansouri A; Friedmann DR; Thomas Roland J; Kondziolka D
J Neurosurg; 2016 Dec; 125(6):1472-1482. PubMed ID: 27035174
[TBL] [Abstract][Full Text] [Related]
8. Facial Nerve Outcomes After Vestibular Schwannoma Microsurgical Resection in Neurofibromatosis Type 2.
Sobieski C; Killeen DE; Barnett SL; Mickey BE; Hunter JB; Isaacson B; Kutz JW
Otolaryngol Head Neck Surg; 2021 Apr; 164(4):850-858. PubMed ID: 32957864
[TBL] [Abstract][Full Text] [Related]
9. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls.
Carlson ML; Tveiten OV; Driscoll CL; Goplen FK; Neff BA; Pollock BE; Tombers NM; Castner ML; Finnkirk MK; Myrseth E; Pedersen PH; Lund-Johansen M; Link MJ
J Neurosurg; 2015 Apr; 122(4):833-42. PubMed ID: 25555165
[TBL] [Abstract][Full Text] [Related]
10. What factors influence treatment decision making in acoustic neuroma? Our experience on 103 cases.
Cassandro C; Albera R; Debiasi L; Albera A; Cassandro E; Scarpa A; Ralli M
Int Tinnitus J; 2020 Nov; 24(1):21-25. PubMed ID: 33206494
[TBL] [Abstract][Full Text] [Related]
11. Audiovestibular symptoms and facial nerve function comparing microsurgery versus SRS for vestibular schwannomas: a systematic review and meta-analysis.
Yakkala VK; Mammi M; Lamba N; Kandikatla R; Paliwal B; Elshibiny H; Corrales CE; Smith TR; Mekary RA
Acta Neurochir (Wien); 2022 Dec; 164(12):3221-3233. PubMed ID: 35962847
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of Radiosurgery Versus Surgery for Neurofibromatosis Type 2 Vestibular Schwannomas.
Chung LK; Nguyen TP; Sheppard JP; Lagman C; Tenn S; Lee P; Kaprealian T; Chin R; Gopen Q; Yang I
World Neurosurg; 2018 Jan; 109():47-58. PubMed ID: 28882713
[TBL] [Abstract][Full Text] [Related]
13. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
[TBL] [Abstract][Full Text] [Related]
15. Targeted Therapies in the Treatment of Vestibular Schwannomas: Current State and New Horizons.
Welling DB
Otolaryngol Clin North Am; 2023 Jun; 56(3):543-556. PubMed ID: 37024334
[TBL] [Abstract][Full Text] [Related]
16. Patient- versus physician-reported facial disability in vestibular schwannoma: an international cross-sectional study.
Tveiten ØV; Carlson ML; Goplen F; Myrseth E; Driscoll CLW; Mahesparan R; Link MJ; Lund-Johansen M
J Neurosurg; 2017 Nov; 127(5):1015-1024. PubMed ID: 27911236
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature.
Wagner J; Welzel T; Habermehl D; Debus J; Combs SE
Tumori; 2014; 100(2):189-94. PubMed ID: 24852864
[TBL] [Abstract][Full Text] [Related]
18. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2.
Choi JW; Lee JY; Phi JH; Wang KC; Chung HT; Paek SH; Kim DG; Park SH; Kim SK
J Neurosurg Pediatr; 2014 Jun; 13(6):650-7. PubMed ID: 24724714
[TBL] [Abstract][Full Text] [Related]
19. Optimal outcomes for hearing preservation in the management of small vestibular schwannomas.
Peng KA; Wilkinson EP
J Laryngol Otol; 2016 Jul; 130(7):606-10. PubMed ID: 27198728
[TBL] [Abstract][Full Text] [Related]
20. Preservation of facial nerve function after resection of vestibular schwannoma.
Sughrue ME; Yang I; Rutkowski MJ; Aranda D; Parsa AT
Br J Neurosurg; 2010 Dec; 24(6):666-71. PubMed ID: 21070151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
